<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01742143</url>
  </required_header>
  <id_info>
    <org_study_id>12-223</org_study_id>
    <nct_id>NCT01742143</nct_id>
  </id_info>
  <brief_title>Impact of ICCAN on Cancer Treatment Completion and Quality of Life</brief_title>
  <official_title>A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>The City College of New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ralph Lauren Center for Cancer Care and Prevention</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lincoln Medical and Mental Health Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lutheran Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <brief_summary>
    <textblock>
      The purpose of this 1 year study is to see if the ICCAN program is working, and to compare&#xD;
      the ICCAN program to the standard hospital services provided in New York City hospitals, like&#xD;
      meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital&#xD;
      guidance).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment completion/adherence</measure>
    <time_frame>1 year</time_frame>
    <description>The primary outcome, cancer treatment completion, will be determined by chart review at 3, 6, and 12 months after enrollment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>1 year</time_frame>
    <description>depression, and stress (measured through validated scales included in the Cancer Treatment Outcomes</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">158</enrollment>
  <condition>Cancer Patients</condition>
  <arm_group>
    <arm_group_label>ICCAN</arm_group_label>
    <description>For those randomized into the ICCAN arm, the core of the intervention will be three ICCAN Access Facilitators who will assess needs and synchronize for each patient an individualized set of transdisciplinary services.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual and Customary Group (U&amp;C)</arm_group_label>
    <description>Participants in this group will receive the same written materials on social and economic resources as ICCAN group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The Integrated Cancer Care Access Network (ICCAN)</intervention_name>
    <description>Patients will receive written materials on social and economic resources and services. Treatment Outcomes Survey at Intake, 3 mo, 6 mo, and 1 year.&#xD;
Chart review at 3 mo, 6 mo and 1 year, and as needed. Plus Initial needs assessment. Assistance with high priority social and economic needs.Monthly follow-up with ICCAN Access Facilitator to address ongoing needs in addition to as-needed assistance.</description>
    <arm_group_label>ICCAN</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual and Customary Group (U&amp;C)</intervention_name>
    <description>Patients will receive written materials on social and economic resources and services. Treatment Outcomes Survey at Intake, 3 mo, 6 mo, and 1 year.&#xD;
Chart review at 3 mo, 6 mo and 1 year, and as needed.</description>
    <arm_group_label>Usual and Customary Group (U&amp;C)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Eligible cancer patients will be recruited in person by multilingual ICCAN Clinical&#xD;
        Research Coordinators for participation in the study at Ralph Lauren Center for Cancer Care&#xD;
        and Prevention (RLCCP), Lincoln Hospital (LH) and Lutheran Medical Center (LMC). In the&#xD;
        event that MSKCC staff is not present when an eligible patient is identified on site,&#xD;
        potential patients may be referred to MSKCC for screening and enrollment using a&#xD;
        Referral/Permission to Contact Form.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  fluent in English, Spanish, or Mandarin&#xD;
&#xD;
          -  between the ages of 21-80 years old&#xD;
&#xD;
          -  cancer patients currently receiving chemotherapy (started within the past month)&#xD;
             and/or radiation therapy (started within the past week), or&#xD;
&#xD;
          -  scheduled to begin chemotherapy and/or radiation therapy within the next 2 months&#xD;
             (excluding surgery only patients)&#xD;
&#xD;
          -  planning on remaining in the area for at least 1 year&#xD;
&#xD;
        Clinician Inclusion Criteria:&#xD;
&#xD;
          -  Has an MD or DO degree&#xD;
&#xD;
          -  Is the treating physician providing care to a patient enrolled to the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diagnosed with Stage IV disease&#xD;
&#xD;
          -  presence of untreated psychiatric disturbance (i.e. acute psychiatric symptoms which&#xD;
             require individual treatment) and/or cognitive impairment disorder (e.g., delirium or&#xD;
             dementia) verified by medical record sufficient to preclude completion of the&#xD;
             assessment measures, interview or informed consent&#xD;
&#xD;
          -  has another family member already enrolled in ICCAN (as determined by patient report)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesca Gany, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lincoln Hospital and Mental Health Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lutheran Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ralph Lauren Center for Cancer Care and Prevention</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org/</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>December 3, 2012</study_first_submitted>
  <study_first_submitted_qc>December 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2012</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Quality of life</keyword>
  <keyword>cancer</keyword>
  <keyword>12-223</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 30, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/43/NCT01742143/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

